Home/ Supplements/ Omega 3/ Omega 3 Fish Oil 800 EPA/500 DHA

Omega 3 Fish Oil 800 EPA/500 DHA

product on market Liquid The Vitamin Shoppe Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 27% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product provides omega-3 fatty acids, specifically EPA and DHA, which have strong evidence for supporting cardiovascular health and cognitive function. These polyunsaturated fats are essential nutrients that the body cannot produce on its own. Research indicates these ingredients are generally safe for consumption at recommended dosages.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3 Fish Oil 800 EPA/500 DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Teaspoon(s)
Serving Size
100
Servings
Fat/Fatty Acid
Product Type
27%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
40 {Calories}
Calories from Fat
40 {Calories}
Total Fat
4 Gram(s)
Saturated Fat
1 mg
Polyunsaturated Fat
2 Gram(s)
Monounsaturated Fat
1 Gram(s)
Cholesterol
15 mg
Omega Fatty Acids
1500 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

natural Lemon flavor Rosemary extract Ascorbyl Palmitate Tocopherol
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Additional Information

Item #: VS-2642 / 1698042

Metadata

Product Details

DSLD Entry Date2013-10-25
Product TypeFat/Fatty Acid
FormLiquid
DSLD ID26980
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.